Share on LinkedInShare on LinkedIn

ARTICLE · 15 FEBRUARY 2019

The Interplay Between The Clinical Trials Regulation And The GDPR

The European Data Protection Board (EDPB) recently adopted its opinion on the interplay between the Clinical Trials Regulation 536/2014 (CTR) and the General Data Protection Regulation 2016/679 (GDPR) (the opinion).

United KingdomPrivacy

The European Data Protection Board (EDPB) recently adopted its opinion on the interplay between the Clinical Trials Regulation 536/2014 (CTR) and the General Data Protection Regulation 2016/679 (GDPR) (the opinion). The opinion was given at the request of the European Commission.

The CTR seeks to harmonise the rules for conducting clinical trials throughout the European Union, and the request for an opinion stemmed from an acknowledgement of the crucial interplay between these two pieces of EU legislation. The EDPB emphasised that interplay by clearing stating in the opinion that the CTR cannot be used as an exemption for compliance with the GDPR.

The opinion distinguishes between the primary use of data and the secondary use of data in clinical trials.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from